Company Overview and News

16
Market Live: Midcap underperforms Sensex; Brent crude dips 1% ahead of OPEC meet

10h moneycontrol
Oil prices dipped as Iran signaled it could be won over to a small rise in OPEC crude output, likely paving the road for the producer cartel to agree on a supply increase during a meeting on June 22.
INDIGO 500325 534690 IBN RELIANCE 532942 539448 539207 KNRCON ICICIBANK LAKSHVILAS HDB 532174 500180 RIGD HDFCBANK MANPASAND RLNIY

21
Market Live: Nifty struggles below 10,800; Jhunjhunwala says 2018 is the year of consolidation

12h moneycontrol
KNR in focus: In a clarification note to the exchanges regarding "Promoters of Company taking large interest free loan from the Company", KNR Constructions said the promoters have extended unsecured loan of Rs 214.08 crore to the company, at the interest rate of 8.45 percent per annum to defray the term loan of one of the SPV. "There are no loans and advances given by the Company to promoters."
OPTOCIRCUI 500325 RELIANCE IDBI 539254 533155 JUBLFOOD 511288 CMQMY RIGD JBLWY CUMMINSIND HDFCBANK 500378 RLNIY SBAZ ADANITRANS GRUH INDIGO 500116 534690 IBN GRHFY 532942 539207 539448 KNRCON 500480 ICICIBANK LAKSHVILAS HDB 532174 500180 JINDALSAW 532391 MANPASAND

12
Market Live: Sensex consolidates amid global trade war fears; ICICI Bank, RIL most active

13h moneycontrol
India signs MOUs for early adoption of 5G: India signed three memoranda of understanding with three top UK academic institutions to facilitate meaningful exploration and early adoption of 5G technology.
GRUH OPTOCIRCUI INDIGO 500116 IBN IDBI 539254 GRHFY 533155 JUBLFOOD 511288 539448 500480 ICICIBANK CMQMY 532174 JINDALSAW JBLWY 532391 CUMMINSIND 500378 SBAZ ADANITRANS

24
Market Update: RIL top Nifty gainer, hits new record high; ICICI, Indigo up 1-2%, Infratel down 3%

14h moneycontrol
The broader indices including the Nifty and the Sensex are trading on a positive note this Thursday morning with the Nifty up 7 points at 10,779 and the Sensex is trading higher by 31 points at 35,578.
SUZLON 500325 TCHQY 532514 532755 SHREECEM IGL 534816 SUEL RLNIY 524804 TATAPOWER APOLLOTYRE AYRQY 532667 TECHM BATAINDIA TATASTEEL TATLY 500180 500387 BHRYY AUROPHARMA GODREJIND RELIANCE 500470 532461 RIGD INFRATEL HDFCBANK INDIGO 517354 HVLQY 500877 IBN 539207 539448 ICICIBANK TTST PNJZY HDB 532174 ARBQY HAVELLS TPCL PNB 500400 500043 500164 MANPASAND

7
InterGlobe Aviation surges 6% on clarification of no summons being issued by ED to co

14h moneycontrol
Shares of InterGlobe Aviation gained around 6 percent in the morning trade as a relief rally was seen on the stock post the management’s clarification.
INDIGO ICICIBANK 532174 IBN 539448

12
Market Live: Sensex opens up 100 pts, Nifty nears 10,800; ICICI Bank, InterGlobe rally

14h moneycontrol
Rupee Update: The rupee slipped 12 paise to 68.20 against the US dollar due to fresh buying of the American currency by importers amid sustained foreign fund outflows. Forex dealers said the dollar hovering near an 11-month high against a basket of currencies overseas, supported by a rise in US yields, also weighed on the rupee but a higher opening of the domestic equity markets limited the fall. Foreign portfolio investors (FPIs) sold shares worth Rs 2,442.
GRUH OPTOCIRCUI INDIGO 500116 IBN IDBI 539254 GRHFY 533155 JUBLFOOD 511288 539448 500480 ICICIBANK CMQMY 532174 JINDALSAW JBLWY 532391 CUMMINSIND 500378 SBAZ ADANITRANS

1
IndiGo shares tank 7.5% after rumours of ED summons

16h freepressjournal.in
Mumbai : InterGlobe Aviation, the parent company of Indigo, on Wednesday clarified that it has not received any summons from Enforcement Directorate (ED) in a case related to violations under Foreign Exchange Management Act (FEMA).
INDIGO KMBKY KOTAKBANK 500247 539448

17
MFs offloaded shares in PowerGrid, InterGlobe Aviation in May

2018-06-20 thehindubusinessline
Suresh P Iyengar The mutual fund industry has offloaded 22 per cent of Power Grid Corporation shares worth ₹1,905 crore in May, as prospects of the company looked bleak with no major new power project being launched and a sharp decline in power generation.
RIFS 532617 HCTHY TTQQY TATACHEM 500390 PIDILITIND PDLTY 532281 HDFCBANK 500770 500331 INDIGO RELEY IBN RELFF JETAIRWAYS 535322 REPCOHOME 539448 RELINFRA ICICIBANK HDB 532174 500180 HCLTECH RIFA 534809 PCJEWELLER

24
Global cues, RIL, banks lift Sensex 261 pts amid rising trade war fears; InterGlobe dips

2018-06-20 moneycontrol
The market recouped its losses seen in the previous session, following the recovery in its global counterparts on Wednesday amid heightened fears of trade war between the world's largest two economies US and China.
YESBANK INDIGO 500325 PAH KMBKY INDUSINDBK IBN RELIANCE HCTHY 532648 YYBKY 539448 ICICIBANK 532187 HDB 532174 500180 RIGD HCLTECH KOTAKBANK 532281 HDFCBANK 500247 RLNIY

7
Interglobe Aviation slips 7% as ED summons top management; Citi maintains sell

2018-06-20 moneycontrol
Shares of InterGlobe Aviation fell 7.5 percent to close at Rs 1,136.15 on Wednesday as investors turned cautious of summons by investigating agencies to its top management.
INDIGO ICICIBANK 532174 IBN 539448

0
Failed Air India sale to swing focus to its asset disposals, cost cuts

2018-06-20 livemint
New Delhi: Air India Ltd needs to spruce up through a fresh cash injection, cost cuts and non-core asset sales, analysts said on Wednesday, after the government indicated a sale of the ailing state-owned carrier had likely been shelved.
INDIGO 539448

0
IndiGo remains top airline in India with 41% market share in May

2018-06-20 livemint
Mumbai: Low-fare airline IndiGo (Interglobe Aviation Ltd) retained its No.1 spot in terms of market share among India’s air passenger careers in May, carrying 4.85 million people during the month. The low-fare airline commanded a 40.9% market share in May, against 39.8% in April, and 41.2% in May 2017, regulatory data released on Tuesday showed.
INDIGO 539448

7
Interglobe Aviation slips 4%; Citi maintains sell, margins could be under pressure

2018-06-20 moneycontrol
Shares of Interglobe Aviation slipped 4.5 percent intraday Wednesday as research house Citi has maintained sell rating on the stock and cut target price to Rs 1,070 from Rs 1,240 per share.
INDIGO ICICIBANK 532174 IBN 539448

5
UPDATE 2-India shelves Air India sale plan after failing to attract buyers - reports

2018-06-20 reuters
, (Reuters) - India has shelved its sale of Air India after failing to attract buyers, local media quoted a government minister as saying - a decision that could exacerbate the carrier’s financial woes and representing a setback for government efforts to cut debt.
INDIGO CLNDY 533278 COALINDIA 539448

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...